These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3288057)

  • 21. Brain resuscitation.
    Henneman EA
    Heart Lung; 1986 Jan; 15(1):3-11. PubMed ID: 3511010
    [No Abstract]   [Full Text] [Related]  

  • 22. [Progress in the study on protective effect of saponins Panax notoginseng on ischemic brain damage].
    Han JA; Hu WY
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1996 Aug; 16(8):506-7. PubMed ID: 9387754
    [No Abstract]   [Full Text] [Related]  

  • 23. Hemodynamic influences of azelnidipine, a novel calcium channel blocker, on cerebral circulation in hypertensive patients with ischemic white matter lesions.
    Kimura Y; Kitagawa K; Oku N; Kajimoto K; Kato H; Tanaka M; Sakaguchi M; Hougaku H; Sakoda S; Hatazawa J
    Hypertens Res; 2008 Dec; 31(12):2147-54. PubMed ID: 19139604
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Ca2+ channel and 5-HT2 receptor antagonist (s)-emopamil in cerebral ischaemia.
    Defeudis FV
    Trends Pharmacol Sci; 1989 Jun; 10(6):215-7. PubMed ID: 2672461
    [No Abstract]   [Full Text] [Related]  

  • 25. [Calcium inhibitors: effects on cerebral blood flow and intracranial pressure].
    Payen D; Lamer C; Raggueneau JL
    Agressologie; 1989 Jun; 30(7):408-10. PubMed ID: 2817237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Experimental studies on pharmacologic protection of the brain against focal ischemia. 2. Effects of KB-2796 and nicardipine on focal brain ischemia in rats].
    Shiino A
    Nihon Geka Hokan; 1989 Sep; 58(5):438-44. PubMed ID: 2642267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Phezam efficacy in patients with chronic cerebral ischemic disease].
    Boĭko AN; Kabanov AA; Es'kina TA; Sheliakina LA; Shchukin AI; Batysheva TT; Artemova IIu; Vdovichenko TV; Volovets SA; Ganzhula PA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(1):36-41. PubMed ID: 15704481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparative study of dilceren (nimodipine) on the cerebral circulation in the intact animals and animals subjected to ischemic brain damage].
    Aleksandrin VV; Khaĭlov NA; Mirzoian GR; Gan'shina TS
    Eksp Klin Farmakol; 2002; 65(2):17-9. PubMed ID: 12109284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel voltage-sensitive Na(+) and Ca(2+) channel blocker, NS-7, prevents suppression of cyclic AMP-dependent protein kinase and reduces infarct area in the acute phase of cerebral ischemia in rat.
    Tanaka K; Ito D; Suzuki S; Dembo T; Kosakai A; Fukuuchi Y
    Brain Res; 2002 Jan; 924(1):98-108. PubMed ID: 11744000
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Drugs acting on calcium channels: potential treatment for ischaemic stroke.
    Alps BJ
    Br J Clin Pharmacol; 1992 Sep; 34(3):199-206. PubMed ID: 1327050
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain ischaemia, calcium and calcium antagonists.
    Nowicki JP; MacKenzie ET; Young AR
    Pathol Biol (Paris); 1982 May; 30(5):282-8. PubMed ID: 7048220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Internal neurology--a. Trends in the study of dementia and cerebrovascular disorders].
    Fukuyama H; Kameyama M
    Nihon Rinsho; 1987 Sep; 45(9):2125-32. PubMed ID: 2892955
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of 1-[bis(4-fluorophenyl)methyl]-4-(2,3,4-trimethoxybenzyl) piperazine dihydrochloride, a new synthesized Ca2+ blocker KB-2796, on free fatty acid liberation in ischemic brain in rats.
    Kanazawa T; Kidooka M; Matsuda M; Handa J
    Nihon Geka Hokan; 1986 Nov; 55(6):755-61. PubMed ID: 3606299
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of calcium antagonists on brain ischemia].
    Naumović N; Slankamenac P; Filipović D; Ivetić V; Todorović ST; Bosković K
    Med Pregl; 2011; 64(5-6):257-61. PubMed ID: 21789914
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Calcium entry blockers in cerebral resuscitation.
    Sakabe T
    Magnesium; 1989; 8(5-6):238-52. PubMed ID: 2693845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroprotective properties of calcium-channel blockers.
    Zornow MH; Prough DS
    New Horiz; 1996 Feb; 4(1):107-14. PubMed ID: 8689265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of calcium channel blockers in acute ischemic cerebrovascular disease.
    Sood AK; Dua A; Mahajan A; Arora S
    J Assoc Physicians India; 1996 Jan; 44(1):70. PubMed ID: 8773106
    [No Abstract]   [Full Text] [Related]  

  • 38. Anatomic considerations in therapeutic arteriogenesis for cerebral ischemia.
    Liebeskind DS
    Circulation; 2004 Jan; 109(2):e4; author reply e4. PubMed ID: 14734507
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of calcium entry blockers in neurological diseases.
    Fieschi C; Lenzi GL; Rasura M
    Eur Neurol; 1986; 25 Suppl 1():68-71. PubMed ID: 3758109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. (S)-emopamil, a novel calcium and serotonin antagonist for the treatment of cerebrovascular disorders. 3rd communication: effect on postischemic cerebral blood flow and metabolism, and ischemic neuronal cell death.
    Szabo L; Hofmann HP
    Arzneimittelforschung; 1989 Mar; 39(3):314-9. PubMed ID: 2757657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.